A division of the Molecular Targets and Medications Discovery Branch
Associate Director for Clinical Research
Triad Technology Center
333 Cassell Dr.
Baltimore, MD 21224
About the Lab
The Medication Development Program’s mission is to develop potential medications to treat substance use disorders from target identification and assay development through licensing NIDA/IRP technology. Our objective is to provide services, training, resources and advice to Investigators who are working on Medication Development projects and can benefit from our skills and expertise.